January 2, 2024 IntegriChain Appoints Seasoned Executive to Lead Data Business for Pharma Distribution and Patient Access IntegriChain appoints Jeff Uccello as Senior Vice President and General Manager of Data Solutions. Uccello is a seasoned pharma data executive with more than 20 years of experience across a wide range of commercialization data and analytics and business leadership roles.
December 19, 2023 IntegriChain Announces Close of Nordic Capital Majority Investment IntegriChain announces close of Nordic Capital majority investment Investment, which will accelerate IntegriChain’s ambitious growth targets and cement its status as a leading commercialization platform for pharma manufacturers.
December 5, 2023 IntegriChain and Blue Fin Group Pharma Trade and Distribution Experts to Speak at Informa Trade & Channel Strategies IntegriChain pharmaceutical strategy expert Bill Roth, General Manager and Managing Partner, Blue Fin Group will be the keynote speaker at Informa’s Trade & Channel Strategies conference. In addition, distribution experts David Weiss, IntegriChain Vice President of Industry Solutions, and Jason Bogroff, Blue Fin Group Partner, will speak at the event.
November 30, 2023 IntegriChain GTN Experts to Speak at Informa’s Pharma/BioTech GTN Summit Philadelphia, PA, November 13, 2023 – IntegriChain, delivering pharma’s only comprehensive technology, data, consulting, and outsourcing platform for data-driven commercialization, today announced that its Gross-to-Net (GTN) experts will present at Informa’s upcoming Pharma | Biotech GTN Summit. Jen Sharpe, Vice President of Gross-to-Net Operational Consulting and facilitator of the Revenue Analytics Collaborative, and Jeff Baab, Vice President of Operational Consulting, have extensive experience in GTN automation, advising Pharma manufacturers of all sizes, business stages, and complexity on SaaS and BPaaS solutions for GTN forecasting, accruals, and analytics. Jen Sharpe is Chairperson and IntegriChain is a sponsor of the conference, which […]
November 8, 2023 Nordic Capital acquires majority share in IntegriChain, the only fully integrated platform for pharma commercialization and market access Nordic Capital has signed an agreement to acquire a majority share in IntegriChain. Nordic Capital is acquiring the majority stake from Accel-KKR, a global software private equity firm, which first invested in IntegriChain in 2016.
November 7, 2023 IntegriChain Presents The Tina Patel Shining Light Award to Patrick Townsend of Vertex Pharmaceuticals IntegriChain presents customer awards to Patrick Townsend of Vertex as well as Johnson & Johnson Innovative Medicine, Alexion Pharmaceuticals, and Tarsus Pharmaceuticals.
October 10, 2023 Key Pharma Commercialization Experts to Converge at Access Insights Conference 2023 The Access Insights Conference 2023 is sponsored by Asembia, AssistRx, BRG, ConnectiveRx, EntityRisk, Pharmaceutical Commerce, Phil, Redi.Health, and Turquoise Health.
September 12, 2023 IntegriChain Expert to Speak on the Inflation Reduction Act at MDRP Summit Pharmaceutical pricing and regulatory expert and Vice President of Operational Consulting Jeff Baab will speak on the impact of the Inflation Reduction Act (IRA) at the Medicaid Drug Rebate Reporting Summit 2023.
June 27, 2023 Blue Fin Group, an IntegriChain Company, Promotes Jason Bogroff to Partner Blue Fin Group promotes seasoned industry advisor Jason Bogroff to partner. In his new role, Bogroff will have direct client responsibility and will lead the firm’s Data Strategy area of focus.
